46 Participants Needed

mHealth Intervention for Cardiac Rehabilitation

CF
LG
Overseen ByLeana Goncalves Araujo, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: AdventHealth University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 2 JurisdictionsThis treatment is already approved in other countries

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment mHealth Intervention for Cardiac Rehabilitation?

Research shows that using digital health interventions, like mobile health (mHealth) and activity trackers, can improve access to cardiac rehabilitation and help tailor recovery programs to individual needs. While some studies did not find significant improvements in physical activity levels at 6 months, there were positive changes in exercise intensity and blood pressure in certain groups, suggesting potential benefits of combining technology with traditional rehabilitation.12345

Is mHealth intervention for cardiac rehabilitation safe for humans?

The research on mHealth interventions, including digital health and activity-monitoring devices, suggests they are generally safe for use in cardiac rehabilitation. These technologies are designed to support heart health and improve patient outcomes without significant safety concerns.14678

How is the mHealth treatment for cardiac rehabilitation different from other treatments?

The mHealth treatment for cardiac rehabilitation is unique because it uses mobile technology to deliver health interventions, making it more accessible and convenient compared to traditional in-person programs. This approach can help overcome barriers like distance and time, allowing patients to engage in rehabilitation activities from home and potentially improving participation and long-term health outcomes.6791011

What is the purpose of this trial?

In this study, the investigators will implement a pilot project of using activity tracker (i.e., Fitbit) with phase III CR clients. The study will record the participants' daily steps and sleep patterns for 8 consecutive weeks in natural settings. Two specific aims are identified for this project:1. Develop an intervention protocol using mHealth to promote Phase III CR clients' self-monitoring of PA.2. Examine the efficacy of the intervention on clients' PA, sleep patterns, functional capacity and QoL.

Eligibility Criteria

This trial is for adults over 18 who are in Phase III Cardiac Rehabilitation (CR) at Hope Clinic. Participants must be able to walk, follow instructions, wear a Fitbit, and use a smartphone with text messaging. They should not be overly active or have upcoming surgery/travel plans within 8 weeks, nor should they be pregnant/lactating or involved in other health programs.

Inclusion Criteria

I am willing to get texts and calls from the research team.
Clients currently receiving Phase III CR at Hope Clinic
I can walk following instructions.
See 4 more

Exclusion Criteria

Clients who are pregnant or lactating
I do not have any surgeries or travel planned in the next 8 weeks.
Clients currently participating in other health promotion program
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
1 visit (in-person)

Intervention

Participants use an activity tracker (i.e., Fitbit) to monitor daily steps and sleep patterns

8 weeks
Continuous monitoring

Follow-up

Participants are monitored for safety and effectiveness after the intervention

4 weeks

Treatment Details

Interventions

  • Mhealth
Trial Overview The study tests an mHealth intervention using activity trackers like Fitbit to monitor physical activity and sleep patterns of Phase III CR clients for 8 weeks. It aims to develop a protocol for self-monitoring and assess the impact on exercise habits, sleep quality, functional capacity, and overall life quality.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Hope ClinicExperimental Treatment2 Interventions
Participants will be recruited from clients admitted to the Phase III CR program at Hope Clinic. An information sheet introducing this study will be provided to clients by the assigned therapist at the Hope clinic after admission.

Mhealth is already approved in United States, European Union for the following indications:

๐Ÿ‡บ๐Ÿ‡ธ
Approved in United States as MHealth Intervention for:
  • Promoting Physical Activity in Cardiac Rehabilitation
๐Ÿ‡ช๐Ÿ‡บ
Approved in European Union as MHealth Intervention for:
  • Supporting Cardiac Rehabilitation through Physical Activity Monitoring

Find a Clinic Near You

Who Is Running the Clinical Trial?

AdventHealth University

Lead Sponsor

Trials
1
Recruited
50+

Findings from Research

A digital health intervention (DHI) combined with remote cardiac rehabilitation (CR) significantly improved access to CR, with 90% of participants completing the program out of 258 who consented from 1,643 referrals.
Participants in the DHI showed notable improvements in their 6-minute walk test distance and reductions in low-density lipoprotein cholesterol, along with a decrease in smoking rates, all without any reported adverse events.
Effects of a patient-centered digital health intervention in patients referred to cardiac rehabilitation: the Smart HEART clinical trial.Harzand, A., Alrohaibani, A., Idris, MY., et al.[2023]
In a study involving 220 low and moderate risk patients undergoing cardiac rehabilitation, a mobile health (mHealth) intervention did not significantly improve physical activity levels, as measured by the 6-minute walk distance, after 6 months compared to usual care.
While the mHealth intervention showed no overall benefit at 6 months, there were some indications of improved outcomes at 3 months for certain users, particularly those using Fitbit devices.
A randomized trial of a mobile health intervention to augment cardiac rehabilitation.Golbus, JR., Gupta, K., Stevens, R., et al.[2023]
The study will evaluate the effectiveness of a mobile health augmented cardiac rehabilitation program (MCard) over 23-24 weeks for improving health-related quality of life (HRQoL) and clinical outcomes in 160 post-acute coronary syndrome (ACS) patients.
If successful, MCard could provide a cost-effective and resource-efficient rehabilitation option that can be scaled to other cardiac centers, especially important during the COVID-19 pandemic.
Mobile Health Augmented Cardiac Rehabilitation (MCard) in Post-Acute Coronary Syndrome Patients: A randomised controlled trial protocol.Hisam, A., Haq, ZU., Khan, Z., et al.[2022]

References

Effects of a patient-centered digital health intervention in patients referred to cardiac rehabilitation: the Smart HEART clinical trial. [2023]
A randomized trial of a mobile health intervention to augment cardiac rehabilitation. [2023]
Mobile Health Augmented Cardiac Rehabilitation (MCard) in Post-Acute Coronary Syndrome Patients: A randomised controlled trial protocol. [2022]
Effectiveness of activity-monitoring devices in patients with cardiovascular disease participating in cardiac rehabilitation programs: an umbrella review protocol. [2023]
Digitally enabled cardiac rehabilitation following coronary revascularization: results from a single centre feasibility study. [2022]
Cardiovascular Disease Self-Management: Pilot Testing of an mHealth Healthy Eating Program. [2022]
Digital Technologies in Cardiac Rehabilitation: A Science Advisory From the American Heart Association. [2023]
Text Message and Internet Support for Coronary Heart Disease Self-Management: Results From the Text4Heart Randomized Controlled Trial. [2023]
Patient interest in mHealth as part of cardiac rehabilitation in Switzerland. [2021]
HEART: heart exercise and remote technologies: a randomized controlled trial study protocol. [2021]
11.United Statespubmed.ncbi.nlm.nih.gov
Virtual AppLication-supported Environment To INcrease Exercise (VALENTINE) during cardiac rehabilitation study: Rationale and design. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity